# Wim van Criekinge

> Wim van Criekinge is a seed investor at Novalis Biotechnology Incubation backing Medical. See 1 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Novalis Biotechnology Incubation](https://shizune.co/investors/profile/novalis-biotechnology-incubation)
- Location: Antwerp, Belgium
- Total investments: 1
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/wvcrieki/
- X (Twitter): https://twitter.com/wvcrieki

Wim van Criekinge is a seed investor at Novalis Biotechnology Incubation in Antwerp focused on Medical and Health Care. Wim van Criekinge is based out of Menlo Park, California and is the Co-Founder of Wintercircus Ghent. Wim van previously worked at OHMX as a Founder and Board Member. Wim van Criekinge attended Harvard Law School.

## Contacts

5 contacts available for Wim van Criekinge: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/wim-van-criekinge-phd?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rarity Bioscience | Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies. | $536.5K | Seed | Feb 06, 2023 | https://raritybioscience.com/ |

1 of 1 investments shown.

## About Novalis Biotechnology Incubation

VC Fund · Gent, Belgium

Novalis Biotech Incubation seeds biotechnology and life sciences-related companies. We focus on early-stage start-ups and support their evolution by providing funding, sharing our professional and academic connections, and help to shape the business strategy in order to create value for all stakeholders.

4 contacts available at Novalis Biotechnology Incubation.

| Name | Title | Profile |
| --- | --- | --- |
| Jan Berghe | Managing Director & Co-Founder | https://shizune.co/investors/profile/jan-berghe |
| Jan Van den Berghe | Co-Founder | https://shizune.co/investors/profile/jan-van-den-berghe |
| Kjell Mortier | Fund Manager | https://shizune.co/investors/profile/kjell-mortier |
| Wim van Criekinge | Co-Founder & Managing Director | https://shizune.co/investors/profile/wim-van-criekinge-phd |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Wim van Criekinge invest in?

Wim van Criekinge invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Wim van Criekinge?

Public channels for Wim van Criekinge include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Wim van Criekinge last invest?

The most recent investment recorded for Wim van Criekinge closed in Feb 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co